We found that EphA2 overexpression contributes to increased myeloid cell populations and decreased T-cell populations, as well as decreased T-cell activation, suggesting it creates an immune suppressive environment that allows tumor cells to grow. The gene discussed is EPHA2; the disease is neoplasm.